These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)]. Manns M MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729 [No Abstract] [Full Text] [Related]
5. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C. Moucari R; Forestier N; Larrey D; Guyader D; Couzigou P; Benhamou Y; Voitot H; Vidaud M; Seiwert S; Bradford B; Zeuzem S; Marcellin P Gut; 2010 Dec; 59(12):1694-8. PubMed ID: 20861007 [TBL] [Abstract][Full Text] [Related]
6. [New triple therapy in chronic hepatitis C. Increased patient chances]. Stiefelhagen P MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830 [No Abstract] [Full Text] [Related]
7. [Treatment of hepatitis C infection. A revolution should not hide another]. Sogni P Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837 [No Abstract] [Full Text] [Related]
8. Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis. Salmerón J; Vinaixa C; Berenguer R; Pascasio JM; Sánchez Ruano JJ; Serra MÁ; Gila A; Diago M; Romero-Gómez M; Navarro JM; Testillano M; Fernández C; Espinosa D; Carmona I; Pons JA; Jorquera F; Rodriguez FJ; Pérez R; Montero JL; Granados R; Fernández M; Martín AB; Muñoz de Rueda P; Quiles R; World J Gastroenterol; 2015 Aug; 21(30):9163-74. PubMed ID: 26290644 [TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy. Inoue T; Hmwe SS; Shimada N; Kato K; Ide T; Torimura T; Kumada T; Toyoda H; Tsubota A; Takaguchi K; Wakita T; Tanaka Y PLoS One; 2017; 12(1):e0170667. PubMed ID: 28118381 [TBL] [Abstract][Full Text] [Related]
10. Infectious diseases. First specific drugs raise hopes for hepatitis C. Enserink M Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720 [No Abstract] [Full Text] [Related]
11. An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments. Cobb B; Vilchez RA Hepatology; 2012 Mar; 55(3):979-80; author reply 980-1. PubMed ID: 22161994 [No Abstract] [Full Text] [Related]
12. [Therapy of hepatitis C: new inhibitors as hammers against HCV]. Bublak R MMW Fortschr Med; 2013 Jun; 155 Suppl 1():10-1. PubMed ID: 23961643 [No Abstract] [Full Text] [Related]
13. Phase 3 study results released for telaprevir and HCV. AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535 [No Abstract] [Full Text] [Related]